COPD Nursing Care Plan Example

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition that requires comprehensive nursing management during acute exacerbations and ongoing education for long-term self-management. This care plan example addresses the key nursing priorities for a patient hospitalized with an acute COPD exacerbation, using standardized NANDA-I diagnoses, NIC interventions, and NOC outcomes.

Condition Overview

COPD encompasses two primary conditions: chronic bronchitis (inflammation and excess mucus production in the bronchial tubes) and emphysema (destruction of alveolar walls, reducing gas exchange surface area and causing air trapping). Most patients have features of both. The disease is characterized by persistent, progressive airflow limitation that is not fully reversible. Severity is classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages based on spirometry (FEV1 percentage of predicted): GOLD 1 (mild), GOLD 2 (moderate), GOLD 3 (severe), and GOLD 4 (very severe).

Smoking is the primary risk factor, accounting for approximately 85-90% of COPD cases, though occupational exposures, air pollution, and alpha-1 antitrypsin deficiency are also significant causes. Acute exacerbations are commonly triggered by respiratory infections (viral or bacterial), air pollution, or medication non-adherence, and are characterized by increased dyspnea, sputum production, and sputum purulence beyond normal day-to-day variation. Exacerbations accelerate lung function decline, increase mortality risk, and are the leading cause of COPD-related hospitalizations.

Typical Patient Presentation

Patients presenting with a COPD exacerbation typically report worsening dyspnea over 1-5 days, increased sputum volume and purulence, chest tightness, and decreased exercise tolerance. They may have a barrel chest (hyperinflated lungs), use accessory muscles of respiration (sternocleidomastoid, intercostals), breathe through pursed lips, and assume a tripod position (leaning forward with hands on knees to improve diaphragmatic mechanics).

Physical assessment reveals decreased breath sounds diffusely, wheezing, prolonged expiratory phase, possible rhonchi (suggesting retained secretions), tachypnea, and tachycardia. In severe exacerbations, cyanosis, altered mental status, and paradoxical abdominal movement (respiratory muscle fatigue) may be present. Arterial blood gases may show respiratory acidosis (elevated PaCO2, decreased pH) with chronic compensatory metabolic alkalosis (elevated bicarbonate). SpO2 may be chronically low (baseline 88-92% for many severe COPD patients), and further drops during exacerbation are clinically significant.

Sample Assessment Scenario

NANDA-I Nursing Diagnoses

1. Impaired Gas Exchange (00030)

Definition: Excess or deficit in oxygenation and/or carbon dioxide elimination at the alveolar-capillary membrane.

Related factors: Ventilation-perfusion imbalance secondary to COPD with emphysematous changes and acute bronchospasm, alveolar-capillary membrane destruction.

Evidence:SpO2 85% (below patient's baseline of 90-92%), PaO2 54 mmHg, PaCO2 56 mmHg (acute-on-chronic hypercapnia), pH 7.32 (respiratory acidosis), tachypnea (RR 28), use of accessory muscles.

2. Ineffective Airway Clearance (00031)

Definition: Inability to clear secretions or obstructions from the respiratory tract to maintain a clear airway.

Related factors: Excessive mucus production, retained secretions, bronchospasm, inflammatory airway changes, infection, impaired ciliary function, fatigue limiting effective cough.

Evidence: Increased sputum production (thick, yellowish-green), rhonchi on auscultation, productive cough with difficulty expectorating, dyspnea, procalcitonin 0.8 ng/mL (suggesting possible bacterial component).

3. Activity Intolerance (00092)

Definition: Insufficient physiological or psychological energy to endure or complete required or desired daily activities.

Related factors: Imbalance between oxygen supply and demand, respiratory muscle fatigue, deconditioning, generalized weakness.

Evidence: Unable to walk to the bathroom without stopping to rest, speaking in 3-4 word phrases, using accessory muscles at rest, SpO2 desaturates with minimal activity.

4. Anxiety (00146)

Definition: Vague, uneasy feeling of discomfort or dread accompanied by an autonomic response.

Related factors: Dyspnea and air hunger (dyspnea-anxiety cycle), threat to current health status, change in health status, history of anxiety disorder.

Evidence:History of anxiety requiring alprazolam, tachycardia (partially anxiety-related), reports feeling "panicky" when short of breath, fearful expression.

NIC Interventions

For Impaired Gas Exchange

• Oxygen Therapy (3320):Titrate supplemental oxygen via Venturi mask (for precise FiO2 control) to target SpO2 88-92%. Avoid high-flow oxygen that may suppress hypoxic respiratory drive and worsen hypercapnia. Monitor ABGs 30-60 minutes after each oxygen adjustment. If hypercapnia worsens (PaCO2 rising with decreasing pH), prepare for non-invasive positive pressure ventilation (BiPAP). Continuous pulse oximetry. Position in high Fowler's or patient-preferred upright position.
• Respiratory Monitoring (3350): Assess respiratory rate, depth, pattern, and work of breathing every 2 hours. Auscultate lung sounds every 4 hours. Monitor mental status closely — somnolence, confusion, or agitation may indicate CO2 retention (CO2 narcosis). Monitor ABG trends. Track serial peak flow or bedside spirometry if available. Prepare for potential ICU escalation if patient shows signs of respiratory failure (worsening acidosis, altered mental status, respiratory fatigue).

For Ineffective Airway Clearance

• Airway Management (3140): Administer nebulized bronchodilators as ordered: short-acting beta-agonist (albuterol 2.5 mg) combined with short-acting anticholinergic (ipratropium 0.5 mg) every 4-6 hours, more frequently in the acute phase if ordered. Administer systemic corticosteroids as ordered (typically prednisone 40 mg daily for 5 days or IV methylprednisolone). Administer antibiotics if prescribed (Anthonisen criteria: 2 of 3 cardinal symptoms — increased dyspnea, increased sputum volume, increased sputum purulence). Ensure adequate humidification. Encourage fluid intake of 2-3 liters per day (unless fluid-restricted) to thin secretions.
• Cough Enhancement (3250):Teach controlled coughing technique (huff cough): take a medium breath, contract abdominal muscles, and force air out with an open glottis ("huff") rather than a forceful closed-glottis cough that can trigger airway collapse. Teach pursed-lip breathing to prevent air trapping during exhalation. Encourage incentive spirometry 10 times every 1-2 hours while awake. Position for optimal drainage. Suction PRN if patient cannot clear secretions effectively.

For Activity Intolerance

• Energy Management (0180): Provide complete rest during the acute phase (first 24-48 hours). Cluster nursing activities to allow uninterrupted rest periods. Assist with all ADLs. Place frequently used items within reach. Supplemental oxygen during any activity. As exacerbation resolves, gradually increase activity with vital sign monitoring before, during, and after (stop if SpO2 drops below 88%, HR increases more than 20 bpm above resting, or patient reports severe dyspnea). Teach energy conservation strategies: sit for tasks, pace activities, prioritize essential tasks, use pursed-lip breathing during exertion.
• Activity Therapy (4310): Coordinate with physical therapy for bedside exercises initially, progressing to hallway ambulation. Set incremental goals: bed mobility → dangle → chair → short hallway walk → longer distances. Document activity tolerance objectively (distance, duration, vital sign response, Borg dyspnea scale). Recommend outpatient pulmonary rehabilitation referral for discharge planning.

For Anxiety

• Anxiety Reduction (5820):Acknowledge the dyspnea-anxiety cycle and validate the patient's feelings. Teach pursed-lip breathing as both a respiratory and anxiety management technique. Maintain a calm, reassuring presence. Administer anxiolytics cautiously (benzodiazepines can suppress respiratory drive — use lowest effective dose, monitor closely). Provide simple, clear explanations of all treatments and procedures. Reduce unnecessary environmental stimulation. Consider non-pharmacological approaches: guided imagery, progressive muscle relaxation, music therapy.

NOC Outcomes

Respiratory Status: Gas Exchange (0402)

• Target: SpO2 maintained at 88-92% on controlled oxygen within 4 hours
• Indicator: PaCO2 returning toward patient's baseline (likely 45-50 mmHg for chronic COPD) within 24-48 hours
• Indicator: pH normalizing above 7.35 with resolution of acute respiratory acidosis
• Indicator: Mental status alert and oriented (no CO2 narcosis)

Respiratory Status: Airway Patency (0410)

• Target: Decreased work of breathing within 24 hours (no accessory muscle use at rest)
• Indicator: Wheezes diminishing with bronchodilator therapy
• Indicator: Sputum transitioning from purulent (yellow-green) to mucoid (clear/white)
• Indicator: Patient demonstrates effective huff cough technique

Activity Tolerance (0005)

• Target: Walks to bathroom without stopping by day 3
• Indicator: SpO2 maintained above 88% during ambulation with supplemental oxygen
• Indicator: Speaks in full sentences at rest by day 2
• Long-term: Returns to pre-exacerbation functional baseline within 4-6 weeks

Anxiety Self-Control (1402)

• Target: Patient reports reduced anxiety with breathing techniques by day 2
• Indicator: Uses pursed-lip breathing independently during dyspneic episodes
• Indicator: Resting heart rate decreasing as anxiety and exacerbation resolve

Discharge Planning Considerations

Discharge readiness for COPD exacerbation includes return to baseline oxygen requirements (or new home oxygen prescription if indicated), ability to use inhalers correctly (demonstrate technique), oral medication transition (complete steroid course at home), ability to perform ADLs at baseline level, and a clear COPD action plan. Arrange follow-up with the pulmonologist or primary care provider within 1-2 weeks. Ensure pneumococcal and influenza vaccinations are current. Provide smoking cessation support if the patient has any ongoing tobacco exposure. Refer to pulmonary rehabilitation (evidence shows starting within 2-4 weeks of discharge reduces readmission). Assess the home oxygen setup — verify the equipment supplier, ensure the patient has sufficient portable oxygen for appointments and activities, and educate on oxygen safety.

Building Your Own COPD Care Plan

COPD care plans must account for GOLD stage, exacerbation severity, comorbidities (heart failure, anxiety/depression, osteoporosis), smoking status, home oxygen status, and individual functional baseline. This example addresses an acute exacerbation in a GOLD 3 patient; a stable COPD patient seen in an outpatient setting would have different priorities focused on maintenance therapy and self-management education.

CarePlanHQgenerates individualized COPD care plans from your patient's assessment data. Enter the respiratory findings, ABG values, functional status, and medication regimen to receive a complete NANDA-I care plan with mapped interventions, measurable outcomes, and a formatted PDF.